Baxter International Inc. (BAX)

NYQ – Real Time Price. Currency in USD

22.04

+0.49 (2.27%)

At close: Jun 26, 2026, 4:00 PM EDT

22.05

+0.01 (0.05%)

After-hours: Jun 26, 2026, 7:50 PM EDT

16.06.2026

Reasons to Retain Baxter International Stock in Your Portfolio for Now

BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.

09.06.2026

Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

13.05.2026

Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

10.05.2026

Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting

Baxter International NYSE: BAX held its 2026 annual meeting of stockholders by webcast, with shareholders giving preliminary approval to all five proposals presented by the company, including the election of nine directors, executive compensation, auditor ratification, an amended incentive plan and a change related to board size.

08.05.2026

Baxter International Still Has A Path To Upside

In recent years, stocks like Baxter International have underperformed: most low-growth, high-debt, struggling names have been bad investments at basically any price. Concerns are real, and early missteps under new CEO Andrew Hider haven't helped. But valuation is attractive not just on an absolute basis but also relative to the outlook, and Q1 results seemed helpful to the bull case.

05.05.2026

Madison Small Cap Fund Q1 2026 Portfolio Activity

ICU Medical's new high-volume pump has more connected features, which we believe will drive retention rates and incremental revenue. SiteOne Landscape Supply controls 18% of this $26 billion industry and has been growing revenue at a low double-digit compound annual growth rate over the past several years. Madison Small Cap Fund liquidated its position in Globus Medical after a multi-year period because the company's success drove its market cap to $12B.

30.04.2026

BAX Stock Gains on Q1 Earnings & Sales Beat, Margins Contract

Baxter beats Q1 earnings and revenue estimates, sending shares higher despite declining profits and margin contraction.

Videos

01.08.2025

Positive

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

01.08.2025

Negative

President Trump demands drugmakers slash prices within 60 days

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
BAX	Argus	Hold	undefined >> undefined	October 31st 2025
BAX	Stifel	Hold	undefined >> $25	August 4th 2025
BAX	Goldman	Neutral	undefined >> $25	August 1st 2025
BAX	Goldman	Buy	undefined >> $42	February 26th 2025
BAX	Argus	Buy	undefined >> undefined	February 24th 2025
BAX	Barclays	Overweight	undefined >> $39	February 20th 2025

Press releases

30.04.2026

Baxter Reports First-Quarter 2026 Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global medtech leader, today reported results for the first quarter of 2026. “Financial results for the quarter overall were in line with our expectations, and we are making progress to stabilize the business, embed a culture of continuous improvement, and strengthen execution,” said Andrew Hider, president and CEO. “Although more work remains to achieve our full potential, Baxter continues to take the decisive steps nec.

13.04.2026

Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, is highlighting recent additions to its Global Surgical Solutions and Patient Support Systems portfolios, as well as its broad Advanced Surgery portfolio of hemostatic and sealing agents, at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo, taking place April 11-14, 2026 in New Orleans. New offerings include the AAT XR spine surgical table and the Dynam.

30.03.2026

Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and platforms, today debuted the IV Verify Line Labeling System, an automated solution, at the 2026 American Organization for Nursing Leadership Conference. The IV Verify system is designed to streamline nursing workflows, save clinician time and support safer medication administration at the bedside. Baxter's launch of the product is the result of a strategic and exclusive distrib.

25.03.2026

Baxter to Host Annual Meeting of Stockholders in Virtual Format

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2026 Annual Meeting) in a virtual format on Tuesday, May 5, 2026 at 9 a.m., Central Time, as disclosed in Baxter's proxy statement for the 2026 Annual Meeting. Online access to the 2026 Annual Meeting will begin at 8:45 a.m., Central Time. Stockholders will not be able to attend the 2026 Annual Meeting in person. The virtual format provides a safe, c.

Baxter International Inc. (BAX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Baxter International Inc. (BAX)

Reasons to Retain Baxter International Stock in Your Portfolio for Now

Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting

Baxter International Still Has A Path To Upside

Madison Small Cap Fund Q1 2026 Portfolio Activity